[Tardive dyskinesia. Synthetic-critical review and case contribution].
The clinical features, etiology and treatment of tardive dyskinesia, a neurological syndrome observed during or after withdrawal of long term neuroleptic therapy, are discussed in reference to the literature records and to the contributions drawn out from 16 new cases.
D000328:Adult; D000368:Aged; D001418:Baclofen / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome; D013747:Tetrabenazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D014149:Tranquilizing Agents; D008750:Methyldopa; D014635:Valproic Acid; D001418:Baclofen; D011736:Pyridoxine; D013747:Tetrabenazine
La discinesia tardiva. Rassegna sintetico-critica e contributo casistico